Prognostic significance of a new grading system of lymph node morphology after neoadjuvant radiochemotherapy for esophageal cancer

Annals of Thoracic Surgery

Volumn 92, Issue 6, 2011, Pages 2020-2027

  Bollschweiler, Elfriede ^a   Hölscher, Arnulf H ^a   Metzger, Ralf ^a   Besch, Sarah ^a   Mönig, Stefan P ^a   Baldus, Stephan E ^b   Drebber, Uta ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; ARTICLE; CANCER GRADING; CANCER RISK; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTINUOUS INFUSION; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FIBROSIS; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MORPHOLOGY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

CHEMORADIOTHERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM GRADING; PROGNOSIS;

EID: 81855213176     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2011.06.091     Document Type: Article

References (34)

1. M. Stahl, M. Walz, and M. Stuschke Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction J Clin Oncol 27 2009 851 856
2. J. Tepper, M. Krasna, and D. Niedzwiecki Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 J Clin Oncol 26 2008 1086 1092
3. D.J. Adelstein, T.W. Rice, and L.A. Rybicki A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity Am J Clin Oncol Cancer Clin Trials 30 2007 172 180 (Pubitemid 46573253)
4. E. Bollschweiler, R. Metzger, and U. Drebber Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis Ann Oncol 20 2009 231 238
5. P. Schneider, S. Baldus, and R. Metzger Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification Ann Surg 242 2005 684 692 (Pubitemid 41567124)
6. C. Mariette, G. Piessen, and N. Briez The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent Ann Surg 247 2008 365 371 (Pubitemid 351156783)
7. K. Prenzel, A. Konig, and P. Schneider Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer Ann Surg Oncol 14 2007 954 959 (Pubitemid 46175347)
8. T.N. Walsh, N. Noonan, and D. Hollywood A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 1996 462 467 (Pubitemid 26269945)
9. I. Rouvelas, W. Zeng, and M. Lindblad Survival after neoadjuvant therapy compared with surgery alone for resectable esophageal cancer in a population-based study World J Surg 30 2006 2182 2189 -2
10. T. Read, J. Andujar, and P. Caushaj Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status Dis Colon Rectum 47 2004 825 831 (Pubitemid 38702600)
11. R. Stupp, M. Mayer, and R. Kann Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial Lancet Oncol 10 2009 785 793
12. H. Miyata, A. Yoshioka, and M. Yamasaki Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy Cancer 115 2009 3324 3334
13. E. Bollschweiler, S. Besch, and U. Drebber Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer Ann Surg Oncol 17 2010 3187 3194
14. M. Caricato, F. Ausania, and E. De Dominicis Tumor regression in mesorectal lymphnodes after neoadjuvant chemoradiation for rectal cancer Eur J Surg Oncol 33 2007 724 728 (Pubitemid 47033809)
15. L. Newman, N. Pernick, and V. Adsay Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcome Ann Surg Oncol 10 2003 734 739 (Pubitemid 40486872)
16. L. Sobin, and C. Wittekind UICC TNM Classification of Malignant Tumors 6th ed. 2002 Wiley & Sons New York, NY
17. A. Hölscher, W. Schroder, and E. Bollschweiler How safe is high intrathoracic esophagogastrostomy? Chirurg 74 2003 726 733 (Pubitemid 38270145)
18. S. Baldus, S. Monig, and W. Schroder Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation Pathologe 25 2004 421 427 (Pubitemid 40022464)
19. E. Bollschweiler, A.H. Holscher, and R. Metzger Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer Future Oncol 6 2010 25 35
20. J. Leers, S. Ayazi, and J. Hagen Survival in lymph node negative adenocarcinoma of the esophagus after R0 resection with and without neoadjuvant therapy: evidence for downstaging of N status J Am Coll Surg 208 2009 553 556
21. A. Greenstein, V. Litle, and S. Swanson Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer Cancer 112 2008 1239 1246 (Pubitemid 351429738)
22. C. Twine, W. Lewis, and M. Morgan The assessment of prognosis of surgically resected oesophageal cancer is dependent on the number of lymph nodes examined pathologically Histopathology 55 2009 46 52
23. M. Wilson, E. Rosato, and K. Chojnacki Prognostic significance of lymph node metastases and ratio in esophageal cancer J Surg Res 146 2008 11 15 (Pubitemid 351442944)
24. N. Altorki, X. Zhou, and B. Stiles Total number of resected lymph nodes predicts survival in esophageal cancer Ann Surg 248 2008 221 226
25. A. Barbour, M. Jones, and M. Gonen Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response Ann Surg Oncol 15 2008 2894 2902
26. A. Mandard, F. Dalibard, and J. Mandard Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma Clinicopathologic correlations Cancer 73 1994 2680 2686 (Pubitemid 24166250)
27. P. Gervaz, L. Rubbia-Brandt, and A. Andres Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes Ann Surg Oncol 17 2010 2714 2719
28. C. Peyre, J. Hagen, and S. De Meester The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection Ann Surg 248 2008 549 556
29. E. Bollschweiler, S. Baldus, and W. Schroder Staging of esophageal carcinoma: Length of tumor and number of involved regional lymph nodes Are these independent prognostic factors? J Surg Oncol 94 2006 355 363 (Pubitemid 44465337)
30. J. Wind, S. Lagarde, and F. Ten Kate A systematic review on the significance of extracapsular lymph node involvement in gastrointestinal malignancies Eur J Surg Oncol 33 2007 401 408 (Pubitemid 46613468)
31. R. Metzger, U. Drebber, and S.E. Baldus Extracapsular lymph node involvement differs between squamous cell and adenocarcinoma of the esophagus Ann Surg Oncol 16 2009 447 453
32. R. Metzger, E. Bollschweiler, and U. Drebber Neoadjuvant chemoradiotherapy for esophageal cancer: impact on extracapsular lymph node involvement World J Gastroenterol 16 2010 1986 1992
33. H. Alakus, A.H. Holscher, and G. Grass Extracapsular lymph node spread: a new prognostic factor in gastric cancer Cancer 116 2010 309 315
34. E. Blackstone Comparing apples and oranges J Thorac Cardiovasc Surg 123 2002 8 15